Dr Amanda Ann Dori, OD | |
915 N St Se Bldg 175, Washington, DC 20374-5162 | |
(202) 433-3937 | |
Not Available |
Full Name | Dr Amanda Ann Dori |
---|---|
Gender | Female |
Speciality | Optometrist |
Location | 915 N St Se Bldg 175, Washington, District Of Columbia |
Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1104057405 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
152W00000X | Optometrist | OEG002219 (Pennsylvania) | Primary |
Mailing Address | Practice Location Address |
---|---|
Dr Amanda Ann Dori, OD 915 N St Se Bldg 175, Washington, DC 20374-5162 Ph: () - | Dr Amanda Ann Dori, OD 915 N St Se Bldg 175, Washington, DC 20374-5162 Ph: (202) 433-3937 |
News Archive
Routine water testing at the Southeastern Veterans' Center in Spring City has identified the presence of Legionella bacteria in the water treatment system. No cases have been reported of any residents having a physical aliment or diagnosis of Legionaries Disease. There is only a presence of the bacteria at this time.
Accelerator Corporation, a privately held, venture-capital-backed biotechnology investment and development company, announced today the Series A financing of Oncofactor Corporation. This is the twelfth company backed by Accelerator and its first investment based on internal intellectual property developed at Accelerator.
Researchers at the University of South Florida have discovered a novel feedback pathway from the brain to the eye that modulates eye pressure - a significant advancement in the effort to diagnose and treat glaucoma.
Agence France-Presse examines how two recent studies have "boosted morale" among HIV vaccine researchers who have struggled for decades to develop a viable vaccine to protect people from the virus. "On September 3, researchers in the United States discovered two potent antibodies - the frontline troops in the immune system - that expose what may prove to be a viral Achilles' heel," the news service writes.
Tumor necrosis factor inhibitors (TNFis) are used to treat inflammatory conditions, such as RA. These agents work by blocking TNF, an important mediator of inflammation in RA, in order to help reduce inflammation and stop disease progression.
› Verified 7 days ago
Dr. John E Bankowski, O.D. Optometrist Medicare: Not Enrolled in Medicare Practice Location: 1100 Connecticut Ave Nw, Washington, DC 20036 Phone: 202-223-1050 | |
M&mak Inc Optometrist Medicare: Not Enrolled in Medicare Practice Location: 801 Pennsylvania Ave Nw, Washington, DC 20004 Phone: 202-783-5318 Fax: 202-783-2020 | |
Metropolitan Eye Associates, Pllc Optometrist Medicare: Not Enrolled in Medicare Practice Location: 3301 New Mexico Ave Nw, Suite 216, Washington, DC 20016 Phone: 202-237-2451 Fax: 202-237-2453 | |
Edwin Siegel, OD Optometrist Medicare: Not Enrolled in Medicare Practice Location: Pentagon Concourse Room 2c113, Pentagon Vision Center, Washington, DC 20301 Phone: 703-920-2020 Fax: 703-920-3852 | |
Columbia Lighthouse For The Blind Optometrist Medicare: Medicare Enrolled Practice Location: 1825 K St Nw, Suite 1103, Washington, DC 20006 Phone: 202-454-6400 Fax: 202-454-6401 | |
Dr. Sara Lee Aggarwal, O.D. Optometrist Medicare: Accepting Medicare Assignments Practice Location: 800 K St Nw, 64, Washington, DC 20001 Phone: 202-898-1060 Fax: 202-898-0472 | |
Washington Eye Associates, Pllc Optometrist Medicare: Not Enrolled in Medicare Practice Location: 1717 Rhode Island Ave Nw, Suite 210, Washington, DC 20036 Phone: 202-558-3824 Fax: 202-558-7517 |